Inhibition of Sclerostin May Increase Cardiovascular Risk
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.